Canaccord conducts a sensitivity analysis of the Israeli pharmaceutical firm InterCure's (INCR) estimated share price in figure 33 on page 30: Figure 33: SOTP sensitivity table Term Growth Rate 3.0% 2.0% 1.5% 1.0% 10.9% 17.47 16.87 16.35 15.88 11.9% 15.53 15.09 14.69 14.33 12.9% 13.98 13.65 13.34 13.07 13.9% 12.72 12.46 12.22 12.00 14.9% 11.67 11.47 11.28 11.10 Source: Canaccord Genuity estimates Estimate the Macaulay duration of INCR's equity. The Macaulay duration is approximately: Select one: O a. 1 year O b. 5 years O c. 10 years O d. 15 years O e. 20 years Discount Rate 2.5% 15.45 14.01 12.81 11.80 10.94 Canaccord conducts a sensitivity analysis of the Israeli pharmaceutical firm InterCure's (INCR) estimated share price in figure 33 on page 30: Figure 33: SOTP sensitivity table Term Growth Rate 3.0% 2.0% 1.5% 1.0% 10.9% 17.47 16.87 16.35 15.88 11.9% 15.53 15.09 14.69 14.33 12.9% 13.98 13.65 13.34 13.07 13.9% 12.72 12.46 12.22 12.00 14.9% 11.67 11.47 11.28 11.10 Source: Canaccord Genuity estimates Estimate the Macaulay duration of INCR's equity. The Macaulay duration is approximately: Select one: O a. 1 year O b. 5 years O c. 10 years O d. 15 years O e. 20 years Discount Rate 2.5% 15.45 14.01 12.81 11.80 10.94